Check Cap Stock

Check Cap EBIT/Assets

The Operating Income to Assets Ratio (EBIT/Assets) of Check Cap (MBAI) as of Aug 2, 2026 is -31.70 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was -6,883.02 % — a change of -99.54% (higher).

EBIT/Assets

-31.70 %

YoY

-99.54%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of Check Cap is 2026 -31.70 % . Operating Income to Assets Ratio (EBIT/Assets) of Check Cap was 2025 -6,883.02 % . It decreases by -99.54% higher compared to the previous year.
Access this data via the Eulerpool API

Check Cap Stock analysis

What does Check Cap do? Check Cap Ltd is an international biotech company specializing in the development of non-invasive diagnostic technologies for early detection of colon cancer. The company is headquartered in Israel and was founded in 2004. Check Cap is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Check Cap stock

Operating Income to Assets Ratio (EBIT/Assets) of Check Cap is -31.70 % in 2026.

Access this data via the Eulerpool API

Profitability — Check Cap

All Key Metrics — Check Cap